Lucid Diagnostics LUCD Annual Recap Lucid Diagnostics posts 2 EPS beat beats consensus loss estimates BFST Biz First Q1 2026 earnings beat estimates as revenue surges 183 percent yearoveryear to 3198M TG Therapeutics TGTX Stock Competitive Analysis Marginal Gain 20260415 The valuation case for Myriad Genetics MYGN that is hard to ignore Smart Money Active 20260508